HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dirk J Duncker Selected Research

uridine adenosine tetraphosphate

1/2019Uridine adenosine tetraphosphate and purinergic signaling in cardiovascular system: An update.
1/2018Uridine Adenosine Tetraphosphate-Induced Coronary Relaxation Is Blunted in Swine With Pressure Overload: A Role for Vasoconstrictor Prostanoids.
11/2013Blunted coronary vasodilator response to uridine adenosine tetraphosphate in post-infarct remodeled myocardium is due to reduced P1 receptor activation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dirk J Duncker Research Topics

Disease

34Myocardial Infarction
01/2021 - 06/2002
25Infarction (Infarctions)
01/2017 - 04/2003
14Ischemia
01/2020 - 07/2002
9Pulmonary Hypertension
12/2021 - 07/2006
8Heart Failure
09/2020 - 04/2003
7Myocardial Ischemia (Ischemic Heart Diseases)
01/2020 - 07/2008
6Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 02/2012
6Hypertrophy
01/2019 - 07/2005
5Diabetes Mellitus
12/2021 - 01/2015
5Fibrosis (Cirrhosis)
09/2020 - 04/2008
5Hypertension (High Blood Pressure)
01/2020 - 01/2012
5Coronary Occlusion
01/2017 - 02/2006
4Hypercholesterolemia
12/2021 - 12/2013
4Atherosclerosis
05/2021 - 12/2002
4Left Ventricular Dysfunction
09/2020 - 06/2002
4ST Elevation Myocardial Infarction
01/2020 - 10/2013
4Hypoxia (Hypoxemia)
01/2020 - 05/2012
4Inflammation (Inflammations)
01/2019 - 06/2003
4Reperfusion Injury
09/2015 - 06/2004
4Ganglion Cysts (Ganglion)
07/2005 - 07/2002
3Cardiotoxicity
01/2021 - 01/2012
3Pulmonary Arterial Hypertension
04/2020 - 01/2018
3Coronary Artery Disease (Coronary Atherosclerosis)
01/2020 - 11/2016
3Hyperlipoproteinemia Type II (Familial Hypercholesterolemia)
11/2019 - 11/2016
3Vascular Diseases (Vascular Disease)
10/2018 - 03/2017
3Hyperemia
04/2017 - 03/2010
3Necrosis
08/2015 - 07/2013
2Chronic Renal Insufficiency
12/2021 - 01/2021
2Neoplasms (Cancer)
01/2021 - 09/2018
2Glycogen Storage Disease Type II (Pompe's Disease)
06/2020 - 07/2010
2Mitochondrial Diseases (Mitochondrial Disease)
01/2020 - 10/2017
2Heart Diseases (Heart Disease)
01/2020 - 01/2008
2Cardiomegaly (Heart Hypertrophy)
01/2020 - 06/2007
2Kidney Diseases (Kidney Disease)
11/2019 - 01/2019
2Cardiomyopathies (Cardiomyopathy)
12/2017 - 04/2015
2Insulin Resistance
07/2017 - 11/2014
2Thrombosis (Thrombus)
10/2016 - 05/2010
2Cicatrix (Scar)
08/2015 - 08/2012
2Body Weight (Weight, Body)
01/2015 - 07/2005
2Pathologic Constriction (Stenosis)
04/2013 - 04/2008
2Aneurysm (Aneurysms)
01/2011 - 03/2007
1Atherosclerotic Plaque (Atheroma)
01/2022
1Ischemic Stroke
01/2022

Drug/Important Bio-Agent (IBA)

15Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2021 - 06/2002
11Proteins (Proteins, Gene)FDA Link
01/2019 - 07/2005
10Endothelins (Endothelin)IBA
12/2021 - 02/2005
10Oxygen (Dioxygen)IBA
01/2020 - 03/2010
10Vasodilator Agents (Vasodilators)IBA
10/2018 - 06/2002
9Vasoconstrictor AgentsIBA
12/2021 - 07/2006
7Nitric Oxide Synthase (NO Synthase)IBA
12/2017 - 06/2002
7Adenosine Triphosphate (ATP)IBA
10/2017 - 06/2002
7Adenosine (Adenocard)FDA LinkGeneric
05/2017 - 07/2002
5Biomarkers (Surrogate Marker)IBA
12/2021 - 01/2012
5Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
01/2020 - 04/2003
4Streptozocin (Streptozotocin)FDA Link
12/2021 - 01/2015
4Phosphotransferases (Kinase)IBA
01/2021 - 03/2008
4Type 5 Cyclic Nucleotide PhosphodiesterasesIBA
01/2019 - 05/2013
4salicylhydroxamic acid (SHAM)IBA
01/2018 - 01/2008
3Pharmaceutical PreparationsIBA
01/2022 - 12/2017
3CytokinesIBA
12/2021 - 08/2015
3uridine adenosine tetraphosphateIBA
01/2019 - 11/2013
3beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA
05/2017 - 07/2005
3Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2013 - 10/2002
3DobutamineFDA LinkGeneric
09/2012 - 06/2010
3Angiotensin IIIBA
05/2008 - 10/2002
3Hexamethonium (Hexamethonium Bromide)IBA
07/2005 - 07/2002
2DNA (Deoxyribonucleic Acid)IBA
01/2021 - 12/2014
2Matrix Metalloproteinases (MMPs)IBA
09/2020 - 10/2003
2Glucose (Dextrose)FDA LinkGeneric
01/2020 - 11/2014
2Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 07/2014
2Endothelin-1 (Endothelin 1)IBA
12/2018 - 04/2008
2Hemoglobins (Hemoglobin)IBA
05/2017 - 03/2010
2Nitroglycerin (Dynamite)FDA LinkGeneric
05/2017 - 11/2014
2HBOC 201 (Hemopure)IBA
05/2017 - 03/2010
2Reactive Oxygen Species (Oxygen Radicals)IBA
03/2017 - 01/2008
2CholesterolIBA
11/2016 - 12/2002
2Fatty Acid Binding Protein 3IBA
02/2016 - 10/2013
2CollagenIBA
08/2015 - 06/2011
2Troponin IIBA
10/2013 - 01/2008
2Adrenergic Agents (Adrenergic Drugs)IBA
04/2012 - 03/2011
2Tyrosine (L-Tyrosine)FDA Link
01/2012 - 06/2004
2ProstaglandinsIBA
09/2011 - 05/2007
2Atrial Natriuretic Factor (ANF)IBA
06/2011 - 04/2008
2fibulinIBA
01/2011 - 03/2007
2Phosphoric Monoester Hydrolases (Phosphatases)IBA
03/2008 - 06/2004
2Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2008 - 07/2002
2Pentobarbital (Nembutal)FDA Link
03/2007 - 07/2005
1HydrogelsIBA
01/2022
1GelatinIBA
01/2022
1LipidsIBA
01/2022
1AlginatesIBA
01/2022
1Tissue Plasminogen Activator (Alteplase)FDA Link
01/2022

Therapy/Procedure

16Therapeutics
01/2022 - 07/2006
5Drug-Eluting Stents
01/2022 - 06/2005
5Percutaneous Coronary Intervention
01/2021 - 01/2012
5Ligation
01/2011 - 09/2005
4Stents
01/2020 - 06/2003
2Microspheres (Microsphere)
01/2018 - 08/2015
2Vagus Nerve Stimulation
09/2015 - 07/2006
2Transplantation
05/2010 - 06/2005